BUSINESS● LOWSep 11 · Sep 11, 2026, 2:10 PM
Exelixis, An IBD 50 Stock, Pulls A Bearish Move With Surprise Cancer Delay
Yahoo Finance · global
Exelixis, a featured stock, experienced a negative market reaction due to an unexpected delay in its cancer-related developments. This event impacted the company's market performance.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS40m agoBlue dollar today: at what price it is quoted this Sunday, November 1ClarínBUSINESS1h agoCompanies promised AI gains— here's how the payoff showed up in earningsCNBC